Reviews

Systematic reviews

Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.

Systematic reviews

Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults

Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity

Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children

Low molecular weight heparin for prevention of microvascular occlusion in digital replantation

Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization

Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children

Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery

Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism

Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients

Heparin for the prevention of intraventricular haemorrhage in preterm infants

Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis

Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease

Heparin versus placebo for non‐ST elevation acute coronary syndromes

Heparin‐bonded catheters for prolonging the patency of central venous catheters in children

Heparin for assisted reproduction

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement